May 30, 2024 Health and Lifestyle 0 Comments Here are 5 stocks that are buys right here, right now [ad_1] Let’s say you just joined the Club, and you are trying to ... Read More
May 30, 2024 Health and Lifestyle 0 Comments Wells Fargo CEO talks up reasons to love the stock — plus, what's behind the market drop [ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch ... Read More
May 29, 2024 Health and Lifestyle 0 Comments We're adding to our geopolitical hedge and a struggling health-care stock [ad_1] We’re adding to our lone oil stock and an out-of-favor medical-technology company. ... Read More
May 24, 2024 Health and Lifestyle 0 Comments Eli Lilly's big GLP-1 investment — plus, what we want from 4 portfolio stock earnings [ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning ... Read More
May 22, 2024 Health and Lifestyle 0 Comments The stock market gets nailed by the Fed, again. Plus, Starbucks' quiet comeback [ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch ... Read More
May 21, 2024 Health and Lifestyle 0 Comments We're encouraged by an activist's willingness to buy an Abbott rival, look past baby formula suits [ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch ... Read More
May 21, 2024 Health and Lifestyle 0 Comments Eli Lilly stock hits new highs after a regulatory win in China. This is a big deal [ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning ... Read More
May 15, 2024 Health and Lifestyle 0 Comments Danaher's rally shows how sticking with a troubled stock of a good company can pay off [ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch ... Read More
May 14, 2024 Health and Lifestyle 0 Comments It's no surprise to see Amazon shares lower after cloud CEO shakeup [ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning ... Read More
May 1, 2024 Health and Lifestyle 0 Comments Eli Lilly assures investors it can overcome the high-quality problem of too much demand [ad_1] Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter ... Read More